Helping Life Science enterprises build for access and impact

AI-first is table stakes; instead, outcomes-first delivery in collaboration with a partner ecosystem unlocks growth, access, and resilience.

You can listen above or watch the videocast here:

Key discussion points include:

• AI-first is no longer differentiating, but outcomes are. Most providers claim AI-first, but the real shift is to outcomes-first delivery tied to better health, better experience, lower cost, and equity.
• The old delivery playbook won’t survive the revenue headwind and patent cliff era. Life science enterprises need a new operating model, Services-as-Software, to rewire discovery-to-commercial and drive measurable impact.
• Winning suppliers become growth partners, not just capacity providers. The next wave is precision medicine, real-world evidence, global resilient supply chains, and continuous patient engagement; vendors that bring IP/platforms and ecosystem innovation move from Horizon 2 toward Horizon 3.

Listen to this conversation and review our perspective here.

Read the HFS Horizons Report on Life Sciences Service Providers, 2025 here.

You can also listen on:

• Apple Podcasts
• Spotify